Key Considerations For Building A Fully Integrated Biopharmaceutical Company

By Evan Loh

With a simple Google search, it’s easy to uncover the reasons why biotech companies find it challenging to successfully implement a fully integrated business model. Supporting and advancing the entire biotech value chain — from drug discovery to manufacturing and commercialization — is costly and requires engagement and advancement in all key functional areas. Moving too quickly to add staff and/or facilities can leave companies vulnerable to resource constraints and operational challenges related to rapid growth.